PL385356A1 - Sposób wytwarzania tadalafilu - Google Patents

Sposób wytwarzania tadalafilu

Info

Publication number
PL385356A1
PL385356A1 PL385356A PL38535608A PL385356A1 PL 385356 A1 PL385356 A1 PL 385356A1 PL 385356 A PL385356 A PL 385356A PL 38535608 A PL38535608 A PL 38535608A PL 385356 A1 PL385356 A1 PL 385356A1
Authority
PL
Poland
Prior art keywords
tadalaphil
production
tadalaphil production
Prior art date
Application number
PL385356A
Other languages
English (en)
Inventor
Łukasz Kaczmarek
Paweł Pyć
Katarzyna Badowska-Rosłonek
Original Assignee
Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna filed Critical Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna
Priority to PL385356A priority Critical patent/PL385356A1/pl
Priority to JP2011512405A priority patent/JP2011522042A/ja
Priority to EP09758588A priority patent/EP2297149A1/en
Priority to US12/996,157 priority patent/US20110124866A1/en
Priority to PCT/PL2009/000060 priority patent/WO2009148341A1/en
Publication of PL385356A1 publication Critical patent/PL385356A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
PL385356A 2008-06-03 2008-06-03 Sposób wytwarzania tadalafilu PL385356A1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL385356A PL385356A1 (pl) 2008-06-03 2008-06-03 Sposób wytwarzania tadalafilu
JP2011512405A JP2011522042A (ja) 2008-06-03 2009-06-03 タダラフィルの製造方法
EP09758588A EP2297149A1 (en) 2008-06-03 2009-06-03 Process for preparation of tadalafil
US12/996,157 US20110124866A1 (en) 2008-06-03 2009-06-03 Process for preparation of tadalafil
PCT/PL2009/000060 WO2009148341A1 (en) 2008-06-03 2009-06-03 Process for preparation of tadalafil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL385356A PL385356A1 (pl) 2008-06-03 2008-06-03 Sposób wytwarzania tadalafilu

Publications (1)

Publication Number Publication Date
PL385356A1 true PL385356A1 (pl) 2009-12-07

Family

ID=40943572

Family Applications (1)

Application Number Title Priority Date Filing Date
PL385356A PL385356A1 (pl) 2008-06-03 2008-06-03 Sposób wytwarzania tadalafilu

Country Status (5)

Country Link
US (1) US20110124866A1 (pl)
EP (1) EP2297149A1 (pl)
JP (1) JP2011522042A (pl)
PL (1) PL385356A1 (pl)
WO (1) WO2009148341A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2541421T3 (es) 2011-02-10 2015-07-20 Interquim, S.A. Procedimiento de obtención de compuestos derivados de tetrahidro-ß-carbolina
CN105106216A (zh) * 2015-09-11 2015-12-02 青岛蓝盛洋医药生物科技有限责任公司 一种治疗男性阳痿的药物他达拉非组合物胶囊
CN110790764B (zh) * 2019-11-27 2021-04-06 四川省通园制药集团有限公司 一种一锅法制备他达拉非的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401090D0 (en) 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
AU2003256539B2 (en) * 2002-07-31 2010-03-04 Icos Corporation Modified pictet-spengler reaction and products prepared therefrom
WO2005068464A2 (en) 2003-12-15 2005-07-28 Cadila Healthcare Limited Process for preparing tadalafil and its intermediates
MX2007010431A (es) * 2005-02-25 2007-10-11 Teva Pharma Proceso para purificar tadalafil.
MX2007012607A (es) 2005-04-12 2008-01-11 Teva Pharma Preparacion de intermedios de tadalafil.
WO2007052283A1 (en) * 2005-10-31 2007-05-10 Alembic Limited An improved process for preparing tadalafil and its intermediate

Also Published As

Publication number Publication date
EP2297149A1 (en) 2011-03-23
US20110124866A1 (en) 2011-05-26
WO2009148341A1 (en) 2009-12-10
JP2011522042A (ja) 2011-07-28

Similar Documents

Publication Publication Date Title
EP2326707A4 (en) PROCESS FOR PRODUCING ISOPRENOIDS
PL2376507T3 (pl) Sposób otrzymywania hydroksymetylofosfonianów
IL205093A0 (en) Method for production of nanofibres
ZA201007720B (en) Production method
EP2271636A4 (en) METHOD FOR PRODUCING DIANEHYDRO SUGAR
GB0711697D0 (en) Method of manufacture
EP2223911A4 (en) PROCESS FOR THE PRODUCTION OF LAUROLACTAM
EP2484816A4 (en) METHOD FOR PRODUCING A LAMINATE
EP2123635A4 (en) PROCESS FOR THE PRODUCTION OF LAUROLACTAM
EP2233548A4 (en) PROCESS FOR PRODUCING FERROCOKE
EP2292579A4 (en) PROCESS FOR THE PRODUCTION OF HALOGENATED FLUOROETHERS
EP2266943A4 (en) PROCESS FOR PRODUCING 2-ALKYL-2-CYCLOALCENE-1-ONE
EP2351818A4 (en) METHOD FOR STARTING A RECTIFICATION COLUMN
GB2457820B (en) Production process
GB0809169D0 (en) Method of L-lysine production
GB0914589D0 (en) Novel compounds and methods for their production
EP2221294A4 (en) PROCESS FOR PREPARING N-CARBAMOYL-TERT.-LEUCIN
PL385356A1 (pl) Sposób wytwarzania tadalafilu
ZA201105114B (en) Method of manufacturing components
EP2251329A4 (en) PROCESS FOR THE PRODUCTION OF 3-AMINO-2-CHLORO-6-TRIFLUOROMETHYLPYRIDINE
GB0822093D0 (en) Improved phospholid and method for its production
GB0904540D0 (en) Novel compounds and methods for their production
PL382168A1 (pl) Sposób wytwarzania S-(-)- 8-metoksy -2 tetralolu
GB0816419D0 (en) Production of hydroelecticity
GB0917817D0 (en) Novel compounds and methods for their production

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed